Trial Profile
Clinical Trials Insight: 700055849
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 May 2010
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 05 May 2010 New trial record